Search
for
Sort by
Research 181–210 of 1000+
- The potential of Clausena anisata (Willd.) Hook.f. ex Benth against Propionibacterium acnes
- Development, validation, and application of an RP-HPLC method for concurrent quantification of Minoxidil and Finasteride in a topical solution for hair regrowth
- Cutaneous toxicities of new treatments for melanoma
- Microscopic polyangiitis secondary to Mycobacterium abscessus in a patient with bronchiectasis: a case report
- Approaches for estimating the clinical starting dose of new dosage forms: An example of a long-acting injectable formulation of finasteride
- Neuronal plasticity of the “brain–skin connection”: stress-triggered up-regulation of neuropeptides in dorsal root ganglia and skin via nerve growth factor-dependent pathways
- Androgens and Parkinson’s disease: the role in humans and in experiment
- Proof-of-Principle Study of Inflammasome Signaling Proteins as Diagnostic Biomarkers of the Inflammatory Response in Parkinson’s Disease
- Effects of α-Synuclein on the Lipid Phenotype of SZ95 Human Sebocytes: A Preliminary Study in the Context of Parkinson’s Disease
- Progress in Dermatology and Venereology in 2023 as reflected in the Journal of the European Academy of Dermatology and Venereology
- Genotype-Phenotype Delineation of Autoimmune Polyendocrinopathy, Candidiasis, and Ectodermal Dystrophy in a Pediatric Patient: A Case Report
- Preparation of a highly specific single chain variable fragment antibody targeting miroestrol and its application in quality control of <i>Pueraria candollei</i> by enzyme‐linked immunosorbent assay
- Effect of 5-alpha reductase inhibitors in animal models of Parkinson’s disease
- Hair metal dysregulation in Parkinson’s disease: Implications for diagnosis and gut-brain axis involvement
- Germline Mutation in ATR in Autosomal- Dominant Oropharyngeal Cancer Syndrome
- Mesenchymal stem cells and their secretome: a promising approach for Parkinson’s disease treatment
- Immunosenescence and inflammaging in Parkinson’s disease: mechanisms and therapeutic prospects
- Abstract 152
- Functionally enhanced placenta-derived mesenchymal stem cells inhibit adipogenesis in orbital fibroblasts with Graves’ ophthalmopathy
- Skin disorders in Parkinson’s disease: potential biomarkers and risk factors
- Is seborrhea a sign of autonomic impairment in Parkinson's disease?
- A regulatory perspective on pharmacokinetic/pharmacodynamic modelling
- Hair glucocorticoid levels in Parkinson’s disease
- Are finasteride-related penile curvature/Peyronie’s disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases
- Home intense pulsed light (IPL) device is a useful tool to decrease hair burden in pilonidal patients – a case series
- Bioinformatic network analysis on the molecular interactions between Parkinson’s disease, alpha-synuclein, and infertility condition
- LB1682 Association of inflammatory and pigmentary disorders with alcohol use disorder and psychiatric illness
- Tackling underrepresentation to aid understanding of Parkinson’s disease: Progress and further opportunities
- Pembrolizumab-Induced Autoimmune Hepatitis
- Tackling underrepresentation to aid understanding of Parkinson’s disease: Progress and further opportunities